| Amrutanjan Healt
|
Amrutanjan Health Care Limited will hold a board meeting on Tuesday, August 11, 2026, in Hyderabad to consider and approve the unaudited financial results along with the limited review report for the quarter ended June 30, 2026. The trading window for equity shares of the company is closed from July 1, 2026, and will remain closed until August 13, 2026, as previously informed on June 24, 2026. |
| Arvind Ltd
|
Arvind Limited has closed its Qualified Institutions Placement (QIP) after receiving applications from eligible Qualified Institutional Buyers (QIBs), the company said in a filing on August 5, 2026. The Finance Committee approved the allocation of 99,00,990 equity shares at an issue price of Rs 505.00 per share, including a discount of Rs 13.58 on the floor price of Rs 518.58, and finalized the allocation note for eligible QIBs. |
| SKF India
|
SKF India Limited will hold a board meeting on Wednesday, August 12, 2026, to consider and approve the unaudited financial results for the first quarter ended June 30, 2026, as stipulated by the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; the trading window for company insiders was closed from July 1, 2026, and will remain so until 48 hours after the financial results are released. |
| Bayer Crop Sci.
|
Bayer CropScience Limited announced that Pankaj Ramanbhai Patel will step down as Chairman and Non-Executive Independent Director on September 11, 2026, following the completion of his second consecutive term, and will also cease to be a member of the Company’s Audit Committee, Corporate Social Responsibility Committee, and Stakeholders’ Relationship Committee. The company further announced the appointment of Ravi Moti Kirpalani as an Additional Independent Director, effective September 1, 2026, for a term until August 31, 2031, subject to shareholder approval, and he will assume the role of Chairman on September 12, 2026. |
| Bharat Forge
|
Bharat Forge Limited will hold a board meeting on August 10, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, and to consider raising funds through various means including equity shares or other convertible securities, subject to shareholder approval and regulatory clearances. Trading window for company directors and designated persons has been closed from July 1, 2026, and will reopen on August 13, 2026. |